T1	Participants 88 134	newly diagnosed stage 1 hypertensive patients]
T2	Participants 409 431	hypertensive patients.
T3	Participants 599 645	newly diagnosed stage 1 hypertensive patients.
T4	Participants 678 758	60 newly diagnosed stage 1 hypertensive patients with no other systemic disease.
T5	Participants 799 813	nebivolol 5 mg
T6	Participants 874 894	and valsartan 160 mg
